Kristine Ball

Overview

Kristine Ball received an average of $1M in total compensation, including $311K in salary, at VYNE Therapeutics from 2017 to 2019.

Source: SEC filings on June 22, 2020 and May 10, 2019.

Related executives

We found seven more executives who work or worked at VYNE Therapeutics.

David Domzalski

VYNE Therapeutics

Chief Executive Officer

Iain Stuart

VYNE Therapeutics

Chief Scientific Officer

Mutya Harsch

VYNE Therapeutics

Chief Legal Officer

Steven Basta

VYNE Therapeutics

Chief Executive Officer

Andrew Saik

VYNE Therapeutics

Chief Financial Officer

Paul Kwon

VYNE Therapeutics

Chief Scientific Officer

Mary Spellman

VYNE Therapeutics

Chief Medical Officer

News

You may also like